BPA Call PC169001-0250
Award Date 12/1/17
Potential Completion Date 10/31/20
Potential Value $3.9K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Hyattsville, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Troop Support Medical awarded a $3,072 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561908794 GLOBULIN RABIES 2ML. The place of performance is Conshohocken, Pennsylvania. The start date is August 23, 2023 and the end date is September 13, 2023. This delivery order was issued against an unidentified medical supply vehicle to procure globulin rabies vaccine for distribution to military treatment facilities by the Defense...
- The Defense Logistics Agency issued an $18,898.32 delivery order to AmerisourceBergen Drug Corp on March 3, 2026, for globulin rabies immunoglobulin, with an ultimate completion date of March 24, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999 through December 2026), which provides pharmaceutical and medical supply support globally for military healthcare programs. Place of performance is Conshohocken, Pennsylvania. Pricing...
- The U.S. Defense Department's Medical Supply Chain awarded a $9,343.53 delivery order to AmerisourceBergen Drug Corp for rabies vaccine (2.5 IU) on May 2, 2025, with an ultimate completion date of May 5, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. The award was placed to AmerisourceBergen's corporate office located in...
- The Defense Logistics Agency issued a $5,987.10 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for 300-unit/mL vials of HYPERRAB (human rabies immune globulin). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which provides global pharmaceutical support to military healthcare programs. Place of performance is Conshohocken, Pennsylvania. The order is firm fixed price with an ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $3,467.48 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. The order, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by December 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,467.48 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product, with a completion date of December 2, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under a competitive procurement process to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $8,954.00 delivery order to AmerisourceBergen Drug Corp for the supply of HYPERRAB 300 Unit/mL Vial 5mL, a rabies immunoglobulin product. The contract was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 15, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency issued a $32,982 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April 6,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $3,609.96 and has an ultimate completion date of August 12, 2024. The contract is for the delivery of a pharmaceutical product, specifically "GLOBULIN,RABIES IMM," to support the recurring medical supply needs of military health facilities...
- The Defense Logistics Agency awarded a $8,954.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of HYPERRAB 300 Unit/ML Vial 5ML, with an ultimate completion date of October 7, 2025. This non-set-aside competitive award was issued on September 16, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HYPERRAB is a rabies immunoglobulin product used for post-exposure rabies prophylaxis in military and federal healthcare...